Vytisknout
1.
BURDA, P.; HLAVACKOVA, A.; POLIVKOVA, V.; CURIK, N.; LAZNICKA, A.; KRIZKOVA, J.; SUTTNAR, J.; KLENER, P.; MACHOVA POLAKOVA, K.G Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events. Molecular metabolism. 2024, vol. 88, no. October, art. no. 102016. ISSN 2212-8778.